Previous 10 | Next 10 |
2023-06-29 19:23:04 ET Accolade, Inc. (ACCD) Q1 2024 Earnings Conference Call June 29, 2023, 04:30 PM ET Company Participants Todd Friedman - SVP, IR Rajeev Singh - CEO Steve Barnes - CFO Shantanu Nundy - Chief Health Officer Conference Call Participant...
2023-06-29 16:10:29 ET Accolade press release ( NASDAQ: ACCD ): Q1 GAAP EPS of -$0.52 beats by $0.09 . Revenue of $93.23M (+9.0% Y/Y) beats by $2.95M . Q2 Outlook: Revenue between $93 million and $95 million Adjusted EBITDA between $(11) million and $(1...
Accolade exceeds guidance for fiscal first quarter and raises guidance for fiscal year 2024 SEATTLE, June 29, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal first quarter ended May 31, 2023. “Our consistently strong financi...
2023-06-23 15:22:26 ET As the end of the second quarter draws near, a range of notable companies are set to release their earnings reports next week. Leading the pack is Nike ( NYSE: NKE ), the footwear and sports apparel giant. Elsewhere, chip makers Micron Technology ( NASDA...
SEATTLE, June 13, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will release fiscal first quarter 2024 financial results on Thursday, June 29, 2023, after the market closes. In conjunction, the company w...
Equip Partnership Adds Eating Disorder Support to Accolade's Trusted Partner Ecosystem PR Newswire Accolade and Equip offer employers purpose-built integrations to address barriers to eating disorder treatment. SEATTLE , June 7, 2023 /PRNewswire/ -- Acc...
Report: Employees are Overwhelmed, Delaying Care at High Rates PR Newswire New health trends report explores causes of stress and offers solutions, including virtual care expansion and enhanced health equity. SEATTLE , June 5, 2023 /PRNewswire/ -- Accolad...
SEATTLE, June 01, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the Stifel 2023 Cross Sector Insight Conference in Boston on Tuesday, June 6, 2023 at 11:30 am ET. A webcast of the e...
2023-05-27 10:24:40 ET Summary ACCD has experienced high demand, with revenue increasing by 5.6% in 4Q23 and a 33% increase in ARR bookings. During the analyst day, ACCD upgraded its FY25 margin target and expressed confidence in reaching $500 million in sales. ACCD's custom-b...
2023-05-24 17:32:31 ET Gainers: NVIDIA Corporation ( NVDA ) +22% . GSI Technology ( GSIT ) +16% . Nutanix ( NTNX ) +14% . Applied Digital ( APLD ) +12% . VNET Group ( VNET ) +10% . Losers: QuantaSing Group ( ...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
A look at the top 10 most actives in the United States Innovative Eyewear Inc. (LUCY) rose 50.0% to $0.495 on volume of 360,218,139 shares NVIDIA Corporation (NVDA) fell 0.4% to $123.54 on volume of 307,578,749 shares Ginkgo Bioworks Holdings Inc. Class A (DNA) rose 8.1% to $0.3343 on vol...